Published in J Pain Symptom Manage on December 01, 2002
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes (2003) 5.58
Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ (2006) 4.79
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes (2007) 3.66
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol (2011) 2.24
Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer (2008) 1.89
Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med (2011) 1.68
Physical and mental health status and health behaviors of childhood cancer survivors: findings from the 2009 BRFSS survey. Pediatr Blood Cancer (2011) 1.66
Restorative yoga for women with breast cancer: findings from a randomized pilot study. Psychooncology (2009) 1.65
Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis. CMAJ (2009) 1.57
Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol (2009) 1.48
Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol (2013) 1.48
The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer (2006) 1.47
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Meaningful change in measures of gait variability in older adults. Gait Posture (2009) 1.43
The Women's wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol. BMC Cancer (2017) 1.41
Evaluating Physical Outcomes in Acute Respiratory Distress Syndrome Survivors: Validity, Responsiveness, and Minimal Important Difference of 4-Meter Gait Speed Test. Crit Care Med (2016) 1.37
Development and psychometric properties of the PROMIS(®) pediatric fatigue item banks. Qual Life Res (2013) 1.27
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage (2010) 1.23
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: effects on quality of life and anthropometric measures. Support Care Cancer (2011) 1.10
Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials. Ann Rheum Dis (2014) 1.10
Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood (2010) 1.10
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol (2013) 1.08
Computerized adaptive testing for follow-up after discharge from inpatient rehabilitation: II. Participation outcomes. Arch Phys Med Rehabil (2008) 1.07
Evaluating the reliability, validity and minimally important difference of the Taiwanese version of the diabetes quality of life (DQOL) measurement. Health Qual Life Outcomes (2008) 1.07
A structured exercise program for patients with advanced non-small cell lung cancer. J Thorac Oncol (2009) 1.06
Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: which differences are clinically important? Health Qual Life Outcomes (2012) 1.01
Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population. Support Care Cancer (2009) 1.01
Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes. Br J Haematol (2008) 1.00
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica (2014) 0.97
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. Am J Hematol (2014) 0.97
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer (2007) 0.96
Determinants of quality of life in patients with advanced cancer. Support Care Cancer (2010) 0.95
Classical homeopathy in the treatment of cancer patients--a prospective observational study of two independent cohorts. BMC Cancer (2011) 0.94
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol (2011) 0.90
The Alberta moving beyond breast cancer (AMBER) cohort study: a prospective study of physical activity and health-related fitness in breast cancer survivors. BMC Cancer (2012) 0.90
Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. Br J Cancer (2014) 0.90
Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia (2013) 0.88
Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors. Health Serv Res (2012) 0.88
Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure. Chest (2015) 0.86
Quality of life: A critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol (2016) 0.85
Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro Oncol (2015) 0.85
Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer (2012) 0.85
Epoetin alfa improves anemia and anemia-related, patient-reported outcomes in patients with breast cancer receiving myelotoxic chemotherapy: results of a European, multicenter, randomized, controlled trial. Oncologist (2010) 0.84
Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice. Support Care Cancer (2014) 0.83
Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial. Support Care Cancer (2013) 0.83
Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancer. BMC Cancer (2012) 0.83
An evaluation of the St Christopher's Hospice rehabilitation gym circuits classes: Patient uptake, outcomes, and feedback. Prog Palliat Care (2014) 0.83
A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer (2013) 0.83
A randomized trial comparing live and telemedicine deliveries of an imagery-based behavioral intervention for breast cancer survivors: reducing symptoms and barriers to care. Psychooncology (2014) 0.83
An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. Support Care Cancer (2012) 0.82
The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol. BMC Cancer (2012) 0.82
A randomized trial of weekly symptom telemonitoring in advanced lung cancer. J Pain Symptom Manage (2013) 0.82
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial. Haematologica (2016) 0.82
Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire. Patient Relat Outcome Meas (2010) 0.82
Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness Therapy-Fatigue subscale for patients with ankylosing spondylitis. Health Qual Life Outcomes (2011) 0.81
Lower brain-derived neurotrophic factor levels associated with worsening fatigue in prostate cancer patients during repeated stress from radiation therapy. World J Biol Psychiatry (2015) 0.81
Diet and physical activity intervention in colorectal cancer survivors: a feasibility study. Eur J Oncol Nurs (2014) 0.80
Age-associated differences in fatigue among patients with cancer. J Pain Symptom Manage (2010) 0.80
Physical activity is associated with clinically important differences in health-related quality of life among rural and small-town breast cancer survivors. Support Care Cancer (2011) 0.79
Comparing and Validating Simple Measures of Patient-Reported Peripheral Neuropathy for Oncology Clinical Trials: NCCTG N0897 (Alliance) A Pooled Analysis of 2440 Patients. SOJ Anesthesiol Pain Manag (2015) 0.78
Criterion validation of the rate of recovery, a single alphanumeric measure, in patients with shoulder pain. Int J Sports Phys Ther (2013) 0.78
Understanding breast cancer patients' preference for two types of exercise training during chemotherapy in an unblinded randomized controlled trial. Int J Behav Nutr Phys Act (2008) 0.78
Order effects: a randomised study of three major cancer-specific quality of life instruments. Health Qual Life Outcomes (2005) 0.78
The use of exercise interventions to overcome adverse effects of androgen deprivation therapy. Nat Rev Urol (2016) 0.78
Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial. Support Care Cancer (2015) 0.78
The minimal clinical important difference in the World Health Organization Quality of Life instrument--100. Support Care Cancer (2012) 0.78
The potential role of exercise in neuro-oncology. Front Oncol (2015) 0.78
A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab. Ther Clin Risk Manag (2016) 0.78
Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report. Oncologist (2016) 0.77
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders. Clin Exp Gastroenterol (2016) 0.77
Pazopanib in the treatment of advanced renal cell carcinoma. Ther Adv Urol (2016) 0.77
Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation. Blood (2013) 0.77
Move onward, press forward, and take a deep breath: can lifestyle interventions improve the quality of life of women with breast cancer, and how can we be sure? J Clin Oncol (2007) 0.77
Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer. Support Care Cancer (2010) 0.77
Web-based stress management for newly diagnosed cancer patients (STREAM-1): a randomized, wait-list controlled intervention study. BMC Cancer (2016) 0.76
Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy. Cancer Nurs (2016) 0.76
Different Phenotyping Approaches Lead to Dissimilar Biologic Profiles in Men With Chronic Fatigue After Radiation Therapy. J Pain Symptom Manage (2016) 0.76
Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline. Support Care Cancer (2004) 0.76
Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial. BMC Cancer (2010) 0.76
Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia. Support Care Cancer (2014) 0.76
Minimal important differences for fatigue patient reported outcome measures-a systematic review. BMC Med Res Methodol (2016) 0.75
Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial. J Cancer Surviv (2017) 0.75
Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study. Cancer Manag Res (2016) 0.75
Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol. BMC Cancer (2017) 0.75
Quality of life of Lithuanian women with early stage breast cancer. BMC Public Health (2007) 0.75
Minimally important differences for Patient Reported Outcomes Measurement Information System pain interference for individuals with back pain. J Pain Res (2016) 0.75
Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis. Brain Behav Immun (2016) 0.75
The role of TRAIL in fatigue induced by repeated stress from radiotherapy. J Psychiatr Res (2017) 0.75
Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life. Rehabil Oncol (2016) 0.75
Translation and validation of the Cancer-Related Fatigue Scale in Greek in a sample of patients with advanced prostate cancer. BMJ Open (2016) 0.75
Diet components associated with perceived fatigue in breast cancer survivors. Eur J Cancer Care (Engl) (2012) 0.75
Association between Daytime Activity, Fatigue, Sleep, Anxiety, Depression, and Symptom Burden in Advanced Cancer Patients: A Preliminary Report. J Palliat Med (2016) 0.75
Physiotherapy programme reduces fatigue in patients with advanced cancer receiving palliative care: randomized controlled trial. Support Care Cancer (2017) 0.75
Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. Radiat Res (2017) 0.75
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol (2010) 10.65
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res (2007) 4.01
Fatigue in cancer patients compared with fatigue in the general United States population. Cancer (2002) 3.34
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol (2007) 2.97
Development of a PROMIS item bank to measure pain interference. Pain (2010) 2.85
Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof (2005) 2.69
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol (2002) 2.64
PROMIS Pediatric Pain Interference Scale: an item response theory analysis of the pediatric pain item bank. J Pain (2010) 2.38
An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales. Qual Life Res (2010) 2.25
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol (2011) 2.24
Construction of the eight-item patient-reported outcomes measurement information system pediatric physical function scales: built using item response theory. J Clin Epidemiol (2011) 2.16
Quality of life after early mitral valve repair using conventional and robotic approaches. Ann Thorac Surg (2012) 2.15
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol (2004) 2.14
Spirituality and religion in patients with HIV/AIDS. J Gen Intern Med (2006) 1.99
Issues in the development of an item bank. Arch Phys Med Rehabil (2003) 1.87
Construction of the Pediatric Asthma Impact Scale (PAIS) for the Patient-Reported Outcomes Measurement Information System (PROMIS). J Asthma (2010) 1.82
Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Serv Res (2014) 1.81
Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research. PLoS Med (2013) 1.79
The neurology quality-of-life measurement initiative. Arch Phys Med Rehabil (2011) 1.71
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage (2007) 1.62
Analysis of differential item functioning in the depression item bank from the Patient Reported Outcome Measurement Information System (PROMIS): An item response theory approach. Psychol Sci Q (2009) 1.56
Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol (2003) 1.48
A 3-factor model for the FACIT-Sp. Psychooncology (2008) 1.41
PROMIS Pediatric Anger Scale: an item response theory analysis. Qual Life Res (2011) 1.39
Motor assessment using the NIH Toolbox. Neurology (2013) 1.34
Religion, spirituality, and depressive symptoms in patients with HIV/AIDS. J Gen Intern Med (2006) 1.25
Linking pain items from two studies onto a common scale using item response theory. J Pain Symptom Manage (2009) 1.25
Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol (2007) 1.25
Assessment is not enough: a randomized controlled trial of the effects of HRQL assessment on quality of life and satisfaction in oncology clinical practice. Psychooncology (2007) 1.24
Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med (2012) 1.23
Norming plans for the NIH Toolbox. Neurology (2013) 1.20
Item banks and their potential applications to health status assessment in diverse populations. Med Care (2006) 1.20
Modeling the effects of spirituality/religion on patients' perceptions of living with HIV/AIDS. J Gen Intern Med (2006) 1.19
Demographic correlates of fatigue in the US general population: results from the patient-reported outcomes measurement information system (PROMIS) initiative. J Psychosom Res (2011) 1.12
Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst (2013) 1.11
PROMIS® Parent Proxy Report Scales: an item response theory analysis of the parent proxy report item banks. Qual Life Res (2011) 1.10
Emotion assessment using the NIH Toolbox. Neurology (2013) 1.10
Upper-extremity and mobility subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank. Arch Phys Med Rehabil (2013) 1.09
Self-reported fatigue: one dimension or more? Lessons from the Functional Assessment of Chronic Illness Therapy--Fatigue (FACIT-F) questionnaire. Support Care Cancer (2010) 1.08
Measuring participation enfranchisement. Arch Phys Med Rehabil (2011) 1.06
Advancing PROMIS's methodology: results of the Third Patient-Reported Outcomes Measurement Information System (PROMIS(®)) Psychometric Summit. Expert Rev Pharmacoecon Outcomes Res (2011) 1.04
Comparison of scoring methods for the participation assessment with recombined tools-objective. Arch Phys Med Rehabil (2011) 1.04
Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire. Value Health (2012) 1.04
Occurrences and sources of Differential Item Functioning (DIF) in patient-reported outcome measures: Description of DIF methods, and review of measures of depression, quality of life and general health. Psychol Sci Q (2008) 1.03
PROMIS Pediatric Peer Relationships Scale: development of a peer relationships item bank as part of social health measurement. Health Psychol (2013) 1.03
An examination of the 3-factor model and structural invariance across racial/ethnic groups for the FACIT-Sp: a report from the American Cancer Society's Study of Cancer Survivors-II (SCS-II). Psychooncology (2010) 1.02
The impact of literacy on health-related quality of life measurement and outcomes in cancer outpatients. Qual Life Res (2006) 1.02
Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psychooncology (2005) 1.01
An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. Neurourol Urodyn (2014) 1.00
Rapid detection of differential item functioning in assessments of health-related quality of life: The Functional Assessment of Cancer Therapy. Qual Life Res (2006) 1.00
Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment. Qual Life Res (2014) 1.00
Item response theory and health-related quality of life in cancer. Expert Rev Pharmacoecon Outcomes Res (2003) 0.99
Beliefs of primary care residents regarding spirituality and religion in clinical encounters with patients: a study at a midwestern U.S. teaching institution. Acad Med (2005) 0.98
Building a measure of fatigue: the functional assessment of Chronic Illness Therapy Fatigue Scale. PM R (2010) 0.98
Advances in quality of life measurements in oncology patients. Semin Oncol (2002) 0.96
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Support Care Cancer (2007) 0.96
Moderators of the benefits of psychoeducational interventions for men with prostate cancer. Health Psychol (2006) 0.95
Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general. Value Health (2007) 0.94
Factors influencing cancer risk perception in high risk populations: a systematic review. Hered Cancer Clin Pract (2011) 0.93
Religion, spirituality, and depressive symptoms in primary care house officers. Ambul Pediatr (2006) 0.93
Linking the activity measure for post acute care and the quality of life outcomes in neurological disorders. Arch Phys Med Rehabil (2011) 0.92
Item-level informant discrepancies between children and their parents on the PROMIS(®) pediatric scales. Qual Life Res (2015) 0.89
Qualitative systematic reviews of treatment burden in stroke, heart failure and diabetes - methodological challenges and solutions. BMC Med Res Methodol (2013) 0.89
Measuring the concerns of cancer patients with low platelet counts: the Functional Assessment of Cancer Therapy--thrombocytopenia (FACT-Th) questionnaire. Support Care Cancer (2006) 0.88
The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma (2012) 0.88
Racial/ethnic differences in spiritual well-being among cancer survivors. J Behav Med (2012) 0.88
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer. J Thorac Oncol (2011) 0.88
Measurement of fatigue in cancer, stroke, and HIV using the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) scale. J Psychosom Res (2012) 0.87
Literacy-fair measurement of health-related quality of life will facilitate comparative effectiveness research in Spanish-speaking cancer outpatients. Med Care (2010) 0.86
Conducting routine fatigue assessments for use in clinical oncology practice: patient and provider perspectives. Support Care Cancer (2007) 0.86
Meta-analysis provides evidence-based effect sizes for a cancer-specific quality-of-life questionnaire, the FACT-G. J Clin Epidemiol (2009) 0.86
Impact of blood pressure dysregulation on health-related quality of life in persons with spinal cord injury: development of a conceptual model. Arch Phys Med Rehabil (2013) 0.84
Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol (2005) 0.84
PROMIS® Parent Proxy Report Scales for children ages 5-7 years: an item response theory analysis of differential item functioning across age groups. Qual Life Res (2013) 0.83
A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care. PLoS Med (2013) 0.82
Validation of the Pediatric Functional Assessment of Cancer Therapy Questionnaire (Version 2.0) in brain tumor survivors aged 13 years and older. J Pain Symptom Manage (2010) 0.82
A qualitative exploration of the experiences of lesbian and heterosexual patients with breast cancer. Oncol Nurs Forum (2002) 0.82
Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol (2010) 0.81
The impact of assistive technology and environmental interventions on function and living situation status with people who are ageing with developmental disabilities. Disabil Rehabil (2002) 0.81
Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI). Breast Cancer Res Treat (2005) 0.81
Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study. Support Care Cancer (2014) 0.80
Age-associated differences in fatigue among patients with cancer. J Pain Symptom Manage (2010) 0.80
Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer (2006) 0.80
Why we need response shift: an appeal to functionalism. Qual Life Res (2010) 0.80
Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement system. Qual Life Res (2013) 0.80
Self-rated health of primary care house officers and its relationship to psychological and spiritual well-being. BMC Med Educ (2007) 0.79
Assessing arm and hand function after stroke: a validity test of the hierarchical scoring system used in the motor assessment scale for stroke. Arch Phys Med Rehabil (2005) 0.78
Validation of pediatric Functional Assessment of Cancer Therapy: patient version 2 of "brain tumor survivor" for grade school patients aged 7-12 years. Qual Life Res (2010) 0.78
Assessing psychological well-being: self-report instruments for the NIH Toolbox. Qual Life Res (2013) 0.77
Have a little faith: measuring the impact of illness on positive and negative aspects of faith. Psychooncology (2011) 0.77
Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness. Arch Dermatol (2007) 0.76
The Postconcussion Symptom Scale: utility of a three-factor structure. Med Sci Sports Exerc (2015) 0.76
An examination of the measurement properties of the pediatric volitional questionnaire. Phys Occup Ther Pediatr (2005) 0.76
The relationships between fatigue, quality of life, and family impact among children with special health care needs. J Pediatr Psychol (2013) 0.76
Validation of Pediatric Functional Assessment of Cancer Therapy Questionnaire (Version 2.0) in Brain Tumor Survivor Aged 13 Years and Older (Parent Form)(PedsFACT-BrS Parent of Adolescent). J Korean Neurosurg Soc (2011) 0.75